Skip to content

Efficacy of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes

Effect of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01429506
Enrollment
30
Registered
2011-09-07
Start date
2011-01-31
Completion date
2012-08-31
Last updated
2015-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Obesity

Keywords

Sleeve gastrectomy, Intensive medical management

Brief summary

In this the investigators will be comparing the effects of Laparoscopic sleeve gastrectomy with intensive medical management on weight and metabolic parameters.

Detailed description

Intensive medical management will include 1. VLCD 2. Physical activity 3. Exenatide 4. Metformin 5. Insulin detemir

Interventions

PROCEDURESleeve gastrectomy

Sleeve gastrectomy

Exenatide 10 mcg BD, Metformin 2-3 gm/day, 800 Kcal diet

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Type 2 Diabetics with 1. BMI ≥ 27.5 kg/m2 2. HbA1c 7-10% 3. Age 20-70 years

Exclusion criteria

1. Prior gastric surgery 2. Pregnancy and lactation 3. renal disease (GFR \< 60 ml/min) 4. Pancreatitis 5. Symptomatic gallstone disease 6. Active malignancy 7. Secondary causes of obesity ( Cushing's syndrome, uncontrolled Hypothyroidism) 8. Severe psychiatric illness 9. Allergic reaction to exenatide

Design outcomes

Primary

MeasureTime frameDescription
weight loss6 monthsweight loss at 6 months after the start of intervention

Secondary

MeasureTime frameDescription
glycemic control6 monthsHbA1c and glucose profile

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026